NO327141B1 - Forbindelsen 9-cis retinsyre for anvendelse ved behandling av eksem samt anvendelse av denne for fremstilling av medikament for behandling av eksem. - Google Patents
Forbindelsen 9-cis retinsyre for anvendelse ved behandling av eksem samt anvendelse av denne for fremstilling av medikament for behandling av eksem. Download PDFInfo
- Publication number
- NO327141B1 NO327141B1 NO20000870A NO20000870A NO327141B1 NO 327141 B1 NO327141 B1 NO 327141B1 NO 20000870 A NO20000870 A NO 20000870A NO 20000870 A NO20000870 A NO 20000870A NO 327141 B1 NO327141 B1 NO 327141B1
- Authority
- NO
- Norway
- Prior art keywords
- eczema
- retinoic acid
- use according
- pharmaceutically acceptable
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97114651A EP0908179A1 (en) | 1997-08-23 | 1997-08-23 | Treatment of cell-mediated immune diseases |
| PCT/EP1998/005236 WO1999009969A1 (en) | 1997-08-23 | 1998-08-18 | Treatment of cell-mediated immune diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20000870D0 NO20000870D0 (no) | 2000-02-22 |
| NO20000870L NO20000870L (no) | 2000-02-22 |
| NO327141B1 true NO327141B1 (no) | 2009-05-04 |
Family
ID=8227266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20000870A NO327141B1 (no) | 1997-08-23 | 2000-02-22 | Forbindelsen 9-cis retinsyre for anvendelse ved behandling av eksem samt anvendelse av denne for fremstilling av medikament for behandling av eksem. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6589989B1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP0908179A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3522220B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR100596260B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1136845C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE259224T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU739440B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI9811989B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2301907C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69821624T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1007020T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2214729T3 (cg-RX-API-DMAC7.html) |
| NO (1) | NO327141B1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ502812A (cg-RX-API-DMAC7.html) |
| PT (1) | PT1007020E (cg-RX-API-DMAC7.html) |
| RU (1) | RU2238083C2 (cg-RX-API-DMAC7.html) |
| TR (1) | TR200000488T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999009969A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8541469B2 (en) * | 1997-08-23 | 2013-09-24 | Glaxo Group Limited | Treatment of cell-mediated immune diseases |
| US20020031539A1 (en) * | 2000-08-30 | 2002-03-14 | The Brigham And Women's Hospital, Inc. | Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma |
| DE10255861A1 (de) * | 2002-11-29 | 2004-06-17 | Axxima Pharmaceuticals Ag | Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen |
| FR2834216B1 (fr) * | 2001-12-27 | 2004-04-30 | Pharmascience Lab | Composition cosmetique ou pharmaceutique comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations |
| JP2004020220A (ja) * | 2002-06-12 | 2004-01-22 | Pioneer Electronic Corp | 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム |
| TW579640B (en) * | 2002-10-23 | 2004-03-11 | Veutron Corp | Light gathering device of scanner |
| EP1527774A1 (en) | 2003-11-03 | 2005-05-04 | Basilea Pharmaceutica AG | New formulation for retinoid-containing soft gelatin capsules |
| US20060281821A1 (en) | 2003-03-14 | 2006-12-14 | Krzysztof Palczewski | Retinoid replacements and opsin agonists and methods for the use thereof |
| WO2004089887A1 (en) | 2003-04-11 | 2004-10-21 | F. Hoffmann-La Roche Ag | Process for the production of 9-cis retinoic acid |
| US7122751B1 (en) * | 2004-01-16 | 2006-10-17 | Cobalt Flux | Switch apparatus |
| US20080274193A1 (en) * | 2004-01-23 | 2008-11-06 | Japan Science And Technology Agency | Retinoic Acid-Containing Antidiabetic Agent |
| AU2005257997B2 (en) | 2004-06-18 | 2012-04-05 | University Of Washington | Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| AU2012216808B2 (en) * | 2004-06-18 | 2015-04-30 | University Of Washington | Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| AU2015207903B2 (en) * | 2004-06-18 | 2017-08-17 | University Of Washington | Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| CN102058571B (zh) * | 2005-09-09 | 2012-09-19 | 有限会社肯菲思 | 4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸在制备用于预防及/或治疗肠疾病的药物中的应用 |
| US8324270B2 (en) | 2008-02-11 | 2012-12-04 | University Of Washington | Methods for the treatment and prevention of age-related retinal dysfunction |
| US8580278B2 (en) * | 2009-06-03 | 2013-11-12 | Trustees Of Dartmouth College | Nutraceutical composition and methods for preventing or treating multiple sclerosis |
| RU2546005C2 (ru) | 2009-09-15 | 2015-04-10 | Кью Эл Ти ИНК. | Фармацевтические составы, содержащие 9-цис-ретиниловые сложные эфиры в липидном наполнителе |
| WO2011056561A1 (en) | 2009-10-27 | 2011-05-12 | Beth Israel Deaconess Medical Center | Methods and compositions for the generation and use of conformation-specific antibodies |
| SG10201507819VA (en) | 2010-04-19 | 2015-10-29 | Quadra Logic Tech Inc | Therapeutic Regimen And Methods For Treating Or Ameliorating Visual Disorders Associated With An Endogenous Retinoid Deficiency |
| WO2012125724A1 (en) | 2011-03-14 | 2012-09-20 | Beth Israel Deaconess Medical Center | Methods and compositions for the treatment of proliferative disorders |
| US10487114B2 (en) | 2011-04-27 | 2019-11-26 | Beth Israel Deaconess Medical Center, Inc. | Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof |
| CN102247348A (zh) * | 2011-05-23 | 2011-11-23 | 天津拓飞生物科技有限公司 | 9-顺式维甲酸在制备治疗糖尿病皮肤溃疡的药物中的应用 |
| US9439884B2 (en) | 2011-05-26 | 2016-09-13 | Beth Israel Deaconess Medical Center, Inc. | Methods for the treatment of immune disorders |
| US9539281B2 (en) | 2011-07-12 | 2017-01-10 | The Brigham And Women's Hospital, Inc. | Lipid-containing PSA compositions, methods of isolation and methods of use thereof |
| AU2013232697B2 (en) | 2012-03-01 | 2017-10-19 | Eluminex Biosciences (Suzhou) Limited | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
| EP2858648B1 (en) | 2012-06-07 | 2018-08-22 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for the inhibition of pin1 |
| CN104583223B (zh) | 2012-08-17 | 2017-04-12 | 巴斯夫欧洲公司 | 烯属化合物的异构化 |
| US9221854B2 (en) | 2012-08-17 | 2015-12-29 | Basf Se | Isomerization of olefinic compounds |
| US20150202172A1 (en) * | 2014-01-22 | 2015-07-23 | Glaxo Group Limited | Novel method of use |
| WO2016011265A2 (en) | 2014-07-17 | 2016-01-21 | Beth Israel Deaconess Medical Center, Inc. | Biomarkers for pin1-associated disorders |
| WO2016011268A1 (en) | 2014-07-17 | 2016-01-21 | Beth Israel Deaconess Medical Center, Inc. | Atra for modulating pin1 activity and stability |
| US10548864B2 (en) | 2015-03-12 | 2020-02-04 | Beth Israel Deaconess Medical Center, Inc. | Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions |
| CN108135167B (zh) | 2015-08-19 | 2021-07-09 | 哈佛学院院长及董事 | 脂化psa组合物和方法 |
| WO2018014012A1 (en) | 2016-07-15 | 2018-01-18 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
| CN113499335B (zh) * | 2021-07-13 | 2023-06-20 | 中国人民解放军军事科学院军事医学研究院 | 一种靶向自噬融合治疗神经退行性疾病的药物 |
| CN122295090A (zh) * | 2023-11-21 | 2026-06-26 | 南京纽邦生物科技有限公司 | 用于改善或维持皮肤、毛囊、头皮或毛发健康的方法和组合物 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525635A (en) * | 1986-02-04 | 1996-06-11 | Moberg; Sven | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof |
| US5093360A (en) * | 1989-04-07 | 1992-03-03 | Yu Ruey J | Retinal, derivatives and their therapeutic use |
| US5057501A (en) * | 1990-03-13 | 1991-10-15 | Dermatologic Research Corporation | Methods for treatment of papulosquamous and eczematous diseases |
| US5932622A (en) * | 1991-12-18 | 1999-08-03 | The Salk Institute For Biological Studies | Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid |
| KR100274101B1 (ko) | 1992-01-22 | 2000-12-15 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 9-시스 레틴산을 함유하는 약제학적 조성물 |
| US5750570A (en) * | 1992-03-31 | 1998-05-12 | The Regents Of The University Of Michigan | Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid |
| CA2093577C (en) | 1992-05-07 | 2006-01-03 | Michael Klaus | Alkyl or alkoxy substituted s-heterocyclic retinoids |
| TW272187B (cg-RX-API-DMAC7.html) * | 1992-05-20 | 1996-03-11 | Hoffmann La Roche | |
| WO1994022818A1 (en) * | 1993-04-05 | 1994-10-13 | Pfizer Inc. | Method for the preparation of 9-cis retinoic acid |
| US5457129A (en) * | 1993-05-17 | 1995-10-10 | Research Development Foundation | Inhibition of nitric oxide production by retinoic acid |
| FR2717686B1 (fr) * | 1994-03-22 | 1996-06-28 | Fabre Pierre Cosmetique | Composition dermo-cosmétologique et procédé de préparation. |
| DE4415204A1 (de) * | 1994-04-30 | 1995-11-02 | Carl Heinrich Dr Weischer | Neue Retinol (Vitamin A) -Derivate, deren Herstellung und Verwendung als Arzneimittel und Kosmetika |
| FR2728790B1 (fr) * | 1994-12-29 | 1997-01-24 | Cird Galderma | Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial |
| US6083977A (en) * | 1994-12-30 | 2000-07-04 | Ligand Pharmaceuticals Incorporated | Trienoic retinoid compounds and methods |
| US5837728A (en) * | 1995-01-27 | 1998-11-17 | Molecular Design International | 9-cis retinoic acid esters and amides and uses thereof |
| FR2735367B1 (fr) * | 1995-06-19 | 1997-07-18 | Cird Galderma | Utilisation de ligands specifiques des recepteurs rxrs |
| FR2752734B1 (fr) * | 1996-09-02 | 1998-11-06 | Cird Galderma | Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf |
| US5994081A (en) * | 1998-04-27 | 1999-11-30 | Incyte Pharamaceuticals, Inc. | Human keratins |
| US20030105031A1 (en) * | 2001-11-06 | 2003-06-05 | Rosenbloom Richard A. | Methods for the treatment of skin disorders |
-
1997
- 1997-08-23 EP EP97114651A patent/EP0908179A1/en not_active Withdrawn
-
1998
- 1998-08-18 KR KR1020007001813A patent/KR100596260B1/ko not_active Expired - Lifetime
- 1998-08-18 CA CA002301907A patent/CA2301907C/en not_active Expired - Lifetime
- 1998-08-18 CN CNB98808743XA patent/CN1136845C/zh not_active Expired - Lifetime
- 1998-08-18 TR TR2000/00488T patent/TR200000488T2/xx unknown
- 1998-08-18 ES ES98947437T patent/ES2214729T3/es not_active Expired - Lifetime
- 1998-08-18 DE DE69821624T patent/DE69821624T2/de not_active Expired - Lifetime
- 1998-08-18 WO PCT/EP1998/005236 patent/WO1999009969A1/en not_active Ceased
- 1998-08-18 EP EP98947437A patent/EP1007020B1/en not_active Expired - Lifetime
- 1998-08-18 AT AT98947437T patent/ATE259224T1/de active
- 1998-08-18 NZ NZ502812A patent/NZ502812A/en not_active IP Right Cessation
- 1998-08-18 BR BRPI9811989A patent/BRPI9811989B8/pt not_active IP Right Cessation
- 1998-08-18 DK DK98947437T patent/DK1007020T3/da active
- 1998-08-18 AU AU94356/98A patent/AU739440B2/en not_active Expired
- 1998-08-18 PT PT98947437T patent/PT1007020E/pt unknown
- 1998-08-18 RU RU2000107124/14A patent/RU2238083C2/ru active
- 1998-08-18 JP JP2000507359A patent/JP3522220B2/ja not_active Expired - Lifetime
- 1998-08-18 US US09/485,943 patent/US6589989B1/en not_active Expired - Lifetime
-
2000
- 2000-02-22 NO NO20000870A patent/NO327141B1/no not_active IP Right Cessation
-
2003
- 2003-06-11 US US10/459,273 patent/US20040039056A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU9435698A (en) | 1999-03-16 |
| NO20000870D0 (no) | 2000-02-22 |
| CN1268886A (zh) | 2000-10-04 |
| CA2301907C (en) | 2009-02-10 |
| WO1999009969A1 (en) | 1999-03-04 |
| US20040039056A1 (en) | 2004-02-26 |
| DK1007020T3 (da) | 2004-06-07 |
| PT1007020E (pt) | 2004-05-31 |
| BR9811989A (pt) | 2000-09-05 |
| NZ502812A (en) | 2002-05-31 |
| CN1136845C (zh) | 2004-02-04 |
| JP3522220B2 (ja) | 2004-04-26 |
| EP1007020A1 (en) | 2000-06-14 |
| ATE259224T1 (de) | 2004-02-15 |
| CA2301907A1 (en) | 1999-03-04 |
| BRPI9811989B1 (pt) | 2015-12-15 |
| RU2238083C2 (ru) | 2004-10-20 |
| KR100596260B1 (ko) | 2006-07-03 |
| NO20000870L (no) | 2000-02-22 |
| TR200000488T2 (tr) | 2000-07-21 |
| EP1007020B1 (en) | 2004-02-11 |
| KR20010023186A (ko) | 2001-03-26 |
| JP2003526595A (ja) | 2003-09-09 |
| EP0908179A1 (en) | 1999-04-14 |
| BRPI9811989B8 (pt) | 2021-05-25 |
| AU739440B2 (en) | 2001-10-11 |
| US6589989B1 (en) | 2003-07-08 |
| DE69821624D1 (de) | 2004-03-18 |
| DE69821624T2 (de) | 2004-09-23 |
| ES2214729T3 (es) | 2004-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1136845C (zh) | 9-顺式视黄酸及其药用盐的用途 | |
| JP5135568B2 (ja) | 心臓血管疾患、関節炎、皮膚ガン、糖尿病、月経前症候群および経皮送達の予防および/または治療のためのオキアミおよび/または海洋生物の抽出物 | |
| US6479544B1 (en) | Therapeutic combinations of fatty acids | |
| EP1392276B1 (en) | Potentiation of therapeutic effects of polyunsaturated fatty acids | |
| US6773708B1 (en) | Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections | |
| NO328797B1 (no) | Anvendelse av essensielle fettsyrer inneholdende en blanding av eikosapentaensyreetylester (EPA) og docosaheksaensyreetylester (DHA) for fremstilling av et medikament nyttig ved forebyggelse av dodsfall hos en pasient som har hatt et hjerteinfarkt. | |
| JPH05316998A (ja) | 食品組成物 | |
| JPH09509139A (ja) | 酪酸エステル細胞分化薬 | |
| AU2019233637B2 (en) | Pharmaceutical or food supplement preparation based on alpha-lactalbumin | |
| JPH06305962A (ja) | アトピー性皮膚炎治療剤 | |
| US8541469B2 (en) | Treatment of cell-mediated immune diseases | |
| US10624907B2 (en) | Production of aspirin-triggered resolvins without the use of aspirin in a dietary omega-3 supplement | |
| MXPA00001803A (en) | Treatment of cell-mediated immune diseases | |
| JPH07233062A (ja) | 人工透析患者の皮膚そう痒症治療組成物及び副甲状腺機能亢進症治療組成物 | |
| HK1059386B (en) | Potentiation of therapeutic effects of polyunsaturated fatty acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: CLAXO GROUP LTD, GB |
|
| CREP | Change of representative |
Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO |
|
| MK1K | Patent expired |